Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03853213 · ClinicalTrials.gov registry record · NA
Investigating Fear Of Recurrence as a Modifiable Mechanism of Behavior Change
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT03853213 is a NA study that has completed, run by Columbia University. The registered enrollment target is 26 participants.
The verdict
NCT03853213, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The primary goal of this project is to identify, measure, and influence fear of cardiac event recurrence, a candidate mechanism of change in medication adherence in patients with suspected acute coronary syndrome (ACS). An intervention will be tested that has been used to reduce fear of cancer recurrence by changing emotion-related patterns of attention allocation and interpretation of neutral stimuli. Secondarily, the study will test whether a reduction in fear of cardiac event recurrence improves medication adherence.
Interventions
- BEHAVIORAL Attention Control Training
- BEHAVIORAL Cognitive Bias Modification Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2019-03-28 |
| Est. Completion | 2020-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03853213
The ClinicalTrials.gov registry entry for NCT03853213 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Attention Control Training is the first listed.
NCT03853213 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03853213 about?
NCT03853213 is a clinical study titled "Investigating Fear Of Recurrence as a Modifiable Mechanism of Behavior Change". The primary goal of this project is to identify, measure, and influence fear of cardiac event recurrence, a candidate mechanism of change in medication adherence in patients with suspected acute coronary syndrome (ACS). An intervention will be tested that has been used to reduce fear of cancer recur...
What is the current status of trial NCT03853213?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2019-03-28. Estimated completion is 2020-07-31.
What interventions are being tested in trial NCT03853213?
The interventions under investigation include: Attention Control Training (BEHAVIORAL), Cognitive Bias Modification Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT03853213?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.